These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 12050096)

  • 1. Androgenetic alopecia and prostate cancer: findings from an Australian case-control study.
    Giles GG; Severi G; Sinclair R; English DR; McCredie MR; Johnson W; Boyle P; Hopper JL
    Cancer Epidemiol Biomarkers Prev; 2002 Jun; 11(6):549-53. PubMed ID: 12050096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early onset baldness and prostate cancer risk.
    Denmark-Wahnefried W; Schildkraut JM; Thompson D; Lesko SM; McIntyre L; Schwingl P; Paulson DF; Robertson CN; Anderson EE; Walther PJ
    Cancer Epidemiol Biomarkers Prev; 2000 Mar; 9(3):325-8. PubMed ID: 10750672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The E211 G>A androgen receptor polymorphism is associated with a decreased risk of metastatic prostate cancer and androgenetic alopecia.
    Hayes VM; Severi G; Eggleton SA; Padilla EJ; Southey MC; Sutherland RL; Hopper JL; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):993-6. PubMed ID: 15824176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baldness, benign prostate hyperplasia, prostate cancer and androgen levels.
    Faydaci G; Bilal E; Necmettin P; Fatih T; Asuman O; Uğur K
    Aging Male; 2008 Dec; 11(4):189-92. PubMed ID: 19172550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum androgens: associations with prostate cancer risk and hair patterning.
    Demark-Wahnefried W; Lesko SM; Conaway MR; Robertson CN; Clark RV; Lobaugh B; Mathias BJ; Strigo TS; Paulson DF
    J Androl; 1997; 18(5):495-500. PubMed ID: 9349747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Male pattern baldness and clinical prostate cancer in the epidemiologic follow-up of the first National Health and Nutrition Examination Survey.
    Hawk E; Breslow RA; Graubard BI
    Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):523-7. PubMed ID: 10815699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-dependent associations between androgenetic alopecia and prostate cancer risk.
    Muller DC; Giles GG; Sinclair R; Hopper JL; English DR; Severi G
    Cancer Epidemiol Biomarkers Prev; 2013 Feb; 22(2):209-15. PubMed ID: 23074289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baldness and myocardial infarction in men: the atherosclerosis risk in communities study.
    Shahar E; Heiss G; Rosamond WD; Szklo M
    Am J Epidemiol; 2008 Mar; 167(6):676-83. PubMed ID: 18208984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cigarette smoking and risk of prostate cancer in middle-aged men.
    Plaskon LA; Penson DF; Vaughan TL; Stanford JL
    Cancer Epidemiol Biomarkers Prev; 2003 Jul; 12(7):604-9. PubMed ID: 12869398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatty acids and risk of prostate cancer in a nested case-control study in male smokers.
    Männistö S; Pietinen P; Virtanen MJ; Salminen I; Albanes D; Giovannucci E; Virtamo J
    Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1422-8. PubMed ID: 14693732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity, adipokines, and prostate cancer in a prospective population-based study.
    Baillargeon J; Platz EA; Rose DP; Pollock BH; Ankerst DP; Haffner S; Higgins B; Lokshin A; Troyer D; Hernandez J; Lynch S; Leach RJ; Thompson IM
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1331-5. PubMed ID: 16835332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Male-Pattern Vertex Baldness Trajectories, Chest Hair Patterns, and Odds of Overall and Aggressive Prostate Cancer.
    Salmon C; Mesidor M; Rousseau MC; Richard H; Weiss D; Spence AR; Parent ME
    Cancer Epidemiol Biomarkers Prev; 2024 Jan; 33(1):143-150. PubMed ID: 37851110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Baldness and coronary artery disease: the dermatologic point of view of a controversial issue.
    Rebora A
    Arch Dermatol; 2001 Jul; 137(7):943-7. PubMed ID: 11453815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indicators of sexual and somatic development and adolescent body size in relation to prostate cancer risk: results from a case-control study.
    Barba M; Terrenato I; Schünemann HJ; Fuhrman B; Sperati F; Teter B; Gallucci M; D'Amato A; Muti P
    Urology; 2008 Jul; 72(1):183-7. PubMed ID: 18280559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary patterns identified using factor analysis and prostate cancer risk: a case control study in Western Australia.
    Ambrosini GL; Fritschi L; de Klerk NH; Mackerras D; Leavy J
    Ann Epidemiol; 2008 May; 18(5):364-70. PubMed ID: 18261927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 5alpha-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia.
    Hayes VM; Severi G; Padilla EJ; Morris HA; Tilley WD; Southey MC; English DR; Sutherland RL; Hopper JL; Boyle P; Giles GG
    Int J Cancer; 2007 Feb; 120(4):776-80. PubMed ID: 17136762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early-onset baldness and the risk of aggressive prostate cancer: findings from a case-control study.
    Papa NP; MacInnis RJ; English DR; Bolton D; Davis ID; Lawrentschuk N; Millar JL; Severi G; Hopper JL; Giles GG
    Cancer Causes Control; 2018 Jan; 29(1):93-102. PubMed ID: 29139043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alcohol and the risk of prostate cancer and benign prostatic hyperplasia.
    Crispo A; Talamini R; Gallus S; Negri E; Gallo A; Bosetti C; La Vecchia C; Dal Maso L; Montella M
    Urology; 2004 Oct; 64(4):717-22. PubMed ID: 15491708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme.
    Pruthi RS; Swords K; Schultz H; Carson CC; Wallen EM
    J Urol; 2009 Feb; 181(2):574-7; discussion 578. PubMed ID: 19084847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men.
    Agalliu I; Weiss NS; Lin DW; Stanford JL
    Cancer Causes Control; 2007 Nov; 18(9):931-7. PubMed ID: 17641982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.